Type of test Blood

Normal findings

Low risk of chromosomal abnormality

 Test explanation and related physiology

 Trisomy 21 (Down syndrome), trisomy 18 (Edwards syn drome), and trisomy 13 (Patau syndrome) are the three most common chromosomal abnormalities affecting live births. Although 1 in 450 live births has one of these aneuploidy abnormalities, trisomy 21 is the most common. Abnormal findings on pelvic ultrasonography of the fetus, including fetal nuchal translucency or thickness along with biochemical markers (e.g., hCG; PAAP-A,), can identify pregnancies at high risk for these chromosomal defects. The definitive diagnosis requires chorionic villus sampling (CVS) and amniocentesis, which are invasive and increase the risk for miscarriage.

Cell-free (cf) DNA from the placental fetal cells circulates in maternal blood. This DNA can be extracted and, through advanced laboratory techniques of targeting genomic sequencing, allows 99% of the cases of trisomy to be detected. False positive rates instigating unnecessary invasive testing are less than 1%. This testing can be performed as early as 10 weeks of gestation but is typically done between 10 and 22 weeks. Because of newer laboratory techniques of multiplexing, results can be available in about 1 week.

In 2012, the American College of Obstetricians and Gynecologists (ACOG) and the Society for Maternal-Fetal Medicine (SMFM) issued a joint committee opinion that supported noninvasive prenatal testing that uses cell-free fetal DNA for women at increased risk for having a baby with a chromosomal abnormality (Box 1).

Box1. Women at high risk for having children with chromosomal abnormalities

Testing of high-risk pregnant women may be done in several ways:

• cf DNA test done in the first trimester along with ultrasonography

• cf DNA test done in the second trimester without ultrasonography C

• A combination of both

Procedure and patient care

• See inside front cover for Routine Blood Testing.

• Fasting: no

 • Blood tube commonly used: red

* Encourage all women undergoing cf DNA to have genetic counseling.

* Results should be reviewed with the patient, and the risks, benefits, and alternatives to further testing should be explained.

 Abnormal findings

- Trisomy 21 (Down syndrome)

- Trisomy 18 (Edwards syndrome)

-Trisomy 13 (Patau syndrome)

- Duchenne muscular dystrophy

- Hemophilia

اخر الاخبار

اخبار العتبة العباسية المقدسة

قسم شؤون المعارف يطلق دورة (صفات الشيعة) لعدد من ملاكات العتبة العباسية المقدسة

الهيأة العليا لإحياء التراث تبحث تعزيز التعاون المشترك مع مركز الإمام الباقر (عليه السلام) في إيران

جامعة الكفيل تكرِّم طلبتها المتميزين من ذوي الاحتياجات الخاصة

فريق طبي في مستشفى الكفيل يجري عملية ناجحة لطفل يعاني من تشوّه ولاديّ بالنخاع الشوكي

المزيد

الآخبار الصحية

خصوصا مع تقدم السن.. 6 سلوكيات يومية قد تدمّر صحتك

فاكهة خضراء.. علاج طبيعي فعّال للإمساك واضطرابات الهضم

روسيا تبدأ أولى التجارب السريرية للقاح واعد ضد السرطان

كنز غذائي على طبقك.. ماذا تفعل السبانخ بجسمك؟

المزيد

الآخبار التكنلوجية

رصد نوع نادر من القطط في تايلاند للمرة الأولى منذ عقود

روسيا تخطط لإقامة محطة نووية في القمر خلال العقد المقبل

كيف قاد إيلون ماسك حملة "غروك" لاختراق عرش الذكاء الاصطناعي

ألتمان: الذكاء الاصطناعي سيتجاوز البشر في 2026 !

المزيد

مواضيع ذات صلة

marijuana (THC) test (Cannabinoid or cannabis testing, Tetrahydrocannabinol [THC] testing)

lung cancer molecular testing (AKT1, ALK, BRAF, Epidermal growth factor [EGFR], HER2, KRAS, MEK1, MET, NRAS, PIK3CA, RET, and ROS1)

kidney stone analysis (Urinary stone analysis, Renal calculus analysis)

Variability and Standardization of CSF Examination

Lab Diagnosis of Yellow fever

hexosaminidase (Hexosaminidase A, Hex A, Total hexosaminidase, Hexosaminidase A and B)

hemoglobin electrophoresis (Hgb electrophoresis)

growth hormone stimulation test (GH provocation test, Insulin tolerance test [ITT], Arginine test, Glucagon Stimulation test)

Markers of Bone Resorption: Amino and Carboxy-Terminal Telopeptides of Collagen Type I

Markers of Bone Resorption: Collagen Cross-Links

Bone Formation Markers : Osteocalcin

Diagnosis of Prion Disease